Adherence and persistence of patients using oral bone sparing drugs in primary care

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Family Practice

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/fampra/cmw120PMID 28334908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy

  2015cited by this paper
• Long-term persistence with anti-osteoporosis drugs after fracture

  2015cited by this paper
• Bisphosphonates for the prevention and treatment of osteoporosis

  2015cited by this paper
• Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures

  2014cited by this paper
• Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management

  2014cited by this paper
• Primary non-adherence to bisphosphonates in an integrated healthcare setting

  2013cited by this paper
• Persistence with osteoporosis medication among newly-treated osteoporotic patients

  2013cited by this paper
• Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway

  2012cited by this paper
• Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA)

  2012cited by this paper
• Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database

  2012cited by this paper
• A meta-analysis of osteoporotic fracture risk with medication nonadherence.

  2011cited by this paper
• GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

  2011cited by this paper
• Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada

  2011cited by this paper
• Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

  2010cited by this paper
• Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

  2010cited by this paper
• Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications

  2010cited by this paper
• Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis

  2009cited by this paper
• The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients.

  2009cited by this paper
• Improving the Prediction of Medication Compliance: The Example of Bisphosphonates for Osteoporosis

  2009cited by this paper
• Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

  2008cited by this paper
• A checklist for medication compliance and persistence studies using retrospective databases.

  2007cited by this paper
• Loss of treatment benefit due to low compliance with bisphosphonate therapy

  2007cited by this paper
• Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

  2006cited by this paper
• Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

  2006cited by this paper
• Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study*

  2006cited by this paper
• Primary non-compliance with prescribed medication in primary care.

  1993cited by this paper
• ICPC : international classification of primary care

  1987cited by this paper

• Primary medication nonadherence in a large primary care population

  2022cites this paper
• Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation

  2020cites this paper
• Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland

  2020cites this paper
• Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria

  2020cites this paper
• Outcome of osteoporosis evaluation, treatment, and follow-up in patients referred to a specialized outpatient clinic compared to patients in care of general practitioners

  2020cites this paper
• Research methods for conducting pharmacoepidemiological studies using medicines claims data

  2019cites this paper
• Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib

  2018cites this paper
• Osteoporosis Treatment Based on Fracture Risk: A Quality of Care Study

  2018cites this paper
• A systematic review of factors affecting medication adherence among patients with osteoporosis

  2018cites this paper
• Manuscript

  2018cites this paper
• Therapietrouw bij bisfosfonaten slecht

  2017cites this paper